Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Terminated 4 Unknown 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depressive Disorder, Major 1 Breast Neoplasms 1

Interventions

Specimen Handling 11 Magnetic Resonance Spectroscopy 9 Cyclophosphamide 9 Bevacizumab 7 pembrolizumab 6 Radiosurgery 6 Cisplatin 6 Oxaliplatin 5 Nivolumab 5 Irinotecan 5 Fluorouracil 5 Everolimus 5 Capecitabine 5 venetoclax 4 Vincristine 4 S 1 (combination) 4 Prednisone 4 Leucovorin 4 Etoposide 4 Drug Therapy 4 Doxorubicin 4 Biopsy 4 Azacitidine 4 fludarabine phosphate 3 fludarabine 3 Tacrolimus 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Rituximab 3 Radiotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER × Escitalopram × Clear all

NCT04973930 2025-05-13

IPT

New York State Psychiatric Institute

Phase 3 Suspended

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡